Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: a case report

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have been emerged as the standard selection in non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutations. However, primar...

Source: BMC Cancer - February 8, 2019 Category: Cancer & Oncology Authors: Junhui Wang and Jianxin Chen Tags: Case report Source Type: research